Fostering innovation with partnerships and collaborations
Creating new and better medicines for patients. This commitment is driven by a strong belief in the power of collaboration.
Search
Partnering
We are convinced that diversity and exchange in science give birth to innovations. For this reason, partnerships are an important component of our innovation strategy.
New cancer research building: Boosting innovation in oncology
With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration.
Meet our Team
Meet our Team
Swine
Swine
Improving Access to Healthcare
According to the UN Sustainable Development Goals, nearly half of the world's population lacks access to basic health care.
Embracing diversity in clinical trials: A global mandate
Have you ever wondered why medicines work differently for different people? Each patient is unique. By embracing diversity in clinical trials, we enable more equitable and inclusive healthcare.
Fighting Foot and Mouth Disease
Foot and mouth disease (FMD) is a highly contagious viral disease that affects cloven-hoofed animals such as cattle, pigs, sheep, and goats. Boehringer Ingelheim France is cooperating with its Kazakh partner QazBioPharm to manufacture vaccines.
More Health: Overview
As a company that operates at the intersection of human and veterinary medicine, we have unique opportunities to advocate for disadvantaged populations.
Research at the Regional Center Vienna
The Regional Center Vienna counts for 33 countries and has been a central pillar in Boehringer Ingelheim’s global research network.
Immune cell directed therapies
Boehringer Ingelheim is committed to transforming cancer care, investigating therapies that target cancer cells and boost the immune system for the benefit of patients.
Biotherapeutics Discovery
Our committed team of scientists are using all their experience and knowledge to forge new research paths, engineer new molecules and do whatever it takes to make sure that no patient is left behind in our search for the next breakthrough.
Our Commitment
Humanity faces great challenges. We believe that we can always do more - for ourselves and for future generations.
Making a difference in clinical trials: The impact of engagement
We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.
We are there for our patients – even in crisis regions.
We are there for our patients – even in crisis regions.
Research Beyond Borders
Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
Veterinarians: caught between excellence and exhaustion
Many children dream of becoming a veterinarian. What happens when that dream comes true?
Pioneering New Medicines Through External Innovation
On 22 November 2024 Boehringer Ingelheim hosted the event “Unleashing Innovation at Boehringer Ingelheim: Pioneering New Medicines Through External Innovation” at the Institute of Molecular Pathology (IMP)